VAERS Explorer
Back to explore

Report #2879629

Received Dec 26, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Influenza like illness

Symptom narrative

experienced flu-like symptoms after getting the Shingrix vaccinations; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: experienced flu-like symptoms after getting the Shingrix vaccinations). The outcome of the influenza-like symptoms was not reported. It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix. It was unknown if the company considered the influenza-like symptoms to be related to Shingrix. Additional Information: GSK Receipt Date: 22-DEC-2025 This case was reported by a patient's father via interactive digital media. The batch number was not provided, and we were unable to contact the reporter.; Sender's Comments: US-GSK-US2021AMR254292:Same reporter US-GSK-US2021AMR254297:Same reporter